cladribine has been researched along with Glioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, D; Gupta, SK; Savardekar, A; Tripathi, M; Vaiphei, K | 1 |
Grieb, P; Jagielski, J; Matyja, E; Mossakowski, MJ; Ryba, M | 1 |
Burch, PA; Dinapoli, RP; Etzell, PS; Leitch, JM; Marks, RS; Morton, RF; Nair, S; O'Fallon, JR; Rajkumar, SV; Scheithauer, B | 1 |
1 trial(s) available for cladribine and Glioma
Article | Year |
---|---|
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Cladribine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 1999 |
2 other study(ies) available for cladribine and Glioma
Article | Year |
---|---|
Isolated tumorous Langerhans cell histiocytosis of the brainstem: a diagnostic and therapeutic challenge.
Topics: Antigens, CD; Antigens, CD1; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Biopsy; Brain Stem; Child; Cladribine; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Glioma; Histiocytosis, Langerhans-Cell; Humans; Male; S100 Proteins; Tuberculosis | 2013 |
Mitochondrial damage following exposure of organotypic cultures of human malignant gliomas to 2-chloro- and 2-bromo-2'-deoxyadenosine.
Topics: Antineoplastic Agents; Astrocytoma; Cell Movement; Cladribine; Culture Techniques; Glioblastoma; Glioma; Humans; Mitochondria | 1996 |